CoChat

Insulin‐like growth factor‐1 stimulates regulatory Tcells and suppresses autoimmune disease

Open access
Bilbao, Daniel, Luciani, Luisa, Johannesson, Bjarki, Piszczek, Agnieszka, Rosenthal, Nadia · 2014 · EMBO Molecular Medicine
Cited by 119

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The recent precipitous rise in autoimmune diseases is placing an increasing clinical and economic burden on health systems worldwide. Current therapies are only moderately efficacious, often coupled with adverse side effects. Here, we show that recombinant human insulin‐like growth factor‐1 (rh IGF ‐1) stimulates proliferation of both human and mouse regulatory T (Treg) cells in vitro and when delivered systemically via continuous minipump, it halts autoimmune disease progression in mouse models of type 1 diabetes ( STZ and NOD ) and multiple sclerosis ( EAE ) in vivo . rh IGF ‐1 administration increased Treg cells in affected tissues, maintaining their suppressive properties. Genetically, ablation of the IGF ‐1 receptor specifically on Treg cell populations abrogated the beneficial effects of rh IGF ‐1 administration on the progression of multiple sclerotic symptoms in the EAE model, establishing a direct effect of IGF ‐1 on Treg cell proliferation. These results establish systemically delivered rh IGF ‐1 as a specific, effective stimulator of Treg cell action, underscoring the clinical feasibility of manipulating natural tolerance mechanisms to suppress autoimmune disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201303376

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Bilbao, D., Luciani, L., Johannesson, B., Piszczek, A., & Rosenthal, N.
Venue
EMBO Molecular Medicine
Published
2014-11
Volume
6
Issue
11
Pages
1423-1435
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2152780155
Cited by
119
References
9
FWCI
3.11
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.